McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:MCK
CUSIP58155Q10
Phone415-983-8300
Debt
Debt-to-Equity Ratio0.68
Current Ratio1.00
Quick Ratio0.57
Price-To-Earnings
Trailing P/E Ratio10.33
Forward P/E Ratio9.78
P/E Growth1.37
Sales & Book Value
Annual Sales$208.36 billion
Price / Sales0.13
Cash Flow$28.4074 per share
Price / Cash4.59
Book Value$48.74 per share
Price / Book2.68
Profitability
EPS (Most Recent Fiscal Year)$12.62
Net Income$67 million
Net Margins-0.18%
Return on Equity25.19%
Return on Assets4.34%
Miscellaneous
Employees78,000
Outstanding Shares199,770,000
Market Cap$25.85 billion
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson declared a quarterly dividend on Thursday, July 26th. Shareholders of record on Tuesday, September 4th will be paid a dividend of $0.39 per share on Monday, October 1st. This represents a $1.56 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date of this dividend is Friday, August 31st. This is an increase from McKesson's previous quarterly dividend of $0.34. View McKesson's Dividend History.
How will McKesson's stock buyback program work?
McKesson declared that its board has initiated a share repurchase program on Thursday, October 27th 2016, which authorizes the company to buyback $4,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 114% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its stock is undervalued.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) released its quarterly earnings results on Thursday, July, 26th. The company reported $2.90 EPS for the quarter, topping the Zacks' consensus estimate of $2.89 by $0.01. The firm had revenue of $52.61 billion for the quarter, compared to analysts' expectations of $52.91 billion. McKesson had a negative net margin of 0.18% and a positive return on equity of 25.19%. The company's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period last year, the firm earned $2.47 EPS. View McKesson's Earnings History.
When is McKesson's next earnings date?
What guidance has McKesson issued on next quarter's earnings?
McKesson issued an update on its FY19 earnings guidance on Thursday, July, 26th. The company provided EPS guidance of $13.00 to $13.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.38.
What price target have analysts set for MCK?
16 brokerages have issued 12 month price targets for McKesson's stock. Their forecasts range from $2.86 to $200.00. On average, they anticipate McKesson's share price to reach $153.3240 in the next year. This suggests a possible upside of 17.6% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 1 sell rating, 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for McKesson.
Who are some of McKesson's key competitors?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman, CEO & Pres (Age 59)
- Britt J. Vitalone, CFO & Exec. VP (Age 49)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 56)
- Mr. Jorge L. Figueredo, Exec. VP of HR (Age 57)
- Mr. Paul C. Julian, Exec. VP (Age 63)
Has McKesson been receiving favorable news coverage?
News headlines about MCK stock have been trending somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. McKesson earned a media and rumor sentiment score of 0.20 on Accern's scale. They also assigned news articles about the company an impact score of 47.42 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for McKesson.
Who are McKesson's major shareholders?
McKesson's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.83%), Massachusetts Financial Services Co. MA (3.31%), Boston Partners (3.12%), FMR LLC (2.20%), Vulcan Value Partners LLC (1.89%) and Bank of New York Mellon Corp (1.45%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson.
Which major investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Robeco Institutional Asset Management B.V., Massachusetts Financial Services Co. MA, Bank of Nova Scotia, Scharf Investments LLC, Ruffer LLP, OMERS ADMINISTRATION Corp and Morgan Stanley. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, John H Hammergren and M Christine Jacobs. View Insider Buying and Selling for McKesson.
Which major investors are buying McKesson stock?
MCK stock was acquired by a variety of institutional investors in the last quarter, including Boston Partners, Vulcan Value Partners LLC, Unigestion Holding SA, Millennium Management LLC, American Century Companies Inc., Pzena Investment Management LLC, Assenagon Asset Management S.A. and Nomura Holdings Inc.. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $130.39.
How big of a company is McKesson?
McKesson has a market capitalization of $25.85 billion and generates $208.36 billion in revenue each year. The company earns $67 million in net income (profit) each year or $12.62 on an earnings per share basis. McKesson employs 78,000 workers across the globe.
How can I contact McKesson?
McKesson's mailing address is ONE POST ST, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
